Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-16 4:50 pm Purchase | 2025-10-10 | 13G | Bluejay Diagnostics, Inc. BJDX | Mitchell P. Kopin | 177,580 9.990% | 177,580 (New Position) | Filing History |
| 2025-10-03 4:50 pm Purchase | 2025-09-29 | 13G | Jiuzi Holdings, Inc. JZXN | Mitchell P. Kopin | 1,062,503 4.990% | 1,062,503 (New Position) | Filing History |
| 2025-10-01 4:48 pm Purchase | 2025-09-25 | 13G | Soligenix, Inc. SNGX | Mitchell P. Kopin | 446,408 4.990% | 446,408 (New Position) | Filing History |
| 2025-09-24 5:17 pm Sale | 2025-09-18 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 1,611 0.400% | -7,051 (-81.40%) | Filing History |
| 2025-09-24 5:13 pm Purchase | 2025-09-18 | 13G | BioCardia, Inc. BCDA | Mitchell P. Kopin | 557,179 4.990% | 557,179 (New Position) | Filing History |
| 2025-09-19 4:34 pm Purchase | 2025-09-16 | 13G | Bionano Genomics, Inc. BNGO | Mitchell P. Kopin | 508,415 4.990% | 508,415 (New Position) | Filing History |
| 2025-09-17 5:14 pm Purchase | 2025-09-11 | 13G | Silexion Therapeutics Ltd. SLXN | Mitchell P. Kopin | 244,771 9.990% | 244,771 (New Position) | Filing History |
| 2025-09-10 6:55 pm Purchase | 2025-09-04 | 13G | Purple Biotech Ltd. PPBT | Mitchell P. Kopin | 139,632,475 9.990% | 139,632,475 (New Position) | Filing History |
| 2025-09-10 6:53 pm Purchase | 2025-09-04 | 13G | Aethlon Medical, Inc. AEMD | Mitchell P. Kopin | 57,660 7.700% | 57,660 (New Position) | Filing History |
| 2025-09-08 06:16 am Purchase | 2025-07-08 | 13G | BNB Plus Corp. BNBX | Mitchell P. Kopin | 143,336 9.990% | 143,336 (New Position) | Filing History |
| 2025-08-25 4:26 pm Purchase | 2025-08-18 | 13G | LM Funding America, Inc. LMFA | Mitchell P. Kopin | 405,440 2.700% | 405,440 (New Position) | Filing History |
| 2025-08-20 4:23 pm Sale | 2025-08-13 | 13G | Color Star Technology Co., Ltd. ADD | Mitchell P. Kopin | 43,791 3.700% | -18,126 (-29.27%) | Filing History |
| 2025-08-15 4:47 pm Purchase | 2025-08-08 | 13G | Longeveron Inc. LGVN | Mitchell P. Kopin | 2,143,418 9.990% | 2,143,418 (New Position) | Filing History |
| 2025-08-12 5:13 pm Purchase | 2025-06-30 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 838,081 9.990% | 53,451 (+6.81%) | Filing History |
| 2025-08-12 5:12 pm Sale | 2025-06-30 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 2,907,250 9.990% | -110,988 (-3.68%) | Filing History |
| 2025-08-12 5:11 pm Purchase | 2025-06-30 | 13G | Microbot Medical Inc. MBOT | Mitchell P. Kopin | 4,200,951 9.990% | 1,851,463 (+78.80%) | Filing History |
| 2025-08-12 5:10 pm Sale | 2025-06-30 | 13G | Mustang Bio, Inc. MBIO | Mitchell P. Kopin | 185,527 4.990% | -50,925 (-21.54%) | Filing History |
| 2025-08-12 5:09 pm Purchase | 2025-06-30 | 13G | Innovative Eyewear, Inc. LUCY | Mitchell P. Kopin | 475,728 9.990% | 142,657 (+42.83%) | Filing History |
| 2025-08-12 5:08 pm Purchase | 2025-06-30 | 13G | Imunon, Inc. IMNN | Mitchell P. Kopin | 1,067,196 4.990% | 993,122 (+1340.71%) | Filing History |
| 2025-08-12 5:08 pm Purchase | 2025-06-30 | 13G | Cemtrex, Inc. CETX | Mitchell P. Kopin | 22,453 9.990% | 9,249 (+70.04%) | Filing History |